中文 - ZH English - EN
关键字搜索批量搜索
全部(4)
Necrosulfonamide is a necroptosis inhibitor by blocking mixed lineage kinase domain-like protein (MLKL), a key substrate of receptor-interacting serine-threonine kinase 3 (RIP3).
TC13172 is a mixed lineage kinase domain-like protein (MLKL) inhibitor with an EC50 value of 2±0.6 nM for HT-29 cells.
GW806742X, an ATP analog, is a potent MLKL inhibitor that binds to the MLKL pseudokinase domain with a Kd value of 9.3μM. GW806742X has anti-VEGFR2 activity (IC50=2 nM). GW806742X delays MLKL membrane displacement and inhibits necrosis.
Necrosulfonamide is a necroptosis inhibitor that selectively targets the mixed lineage kinase domain-like protein (MLKL), preventing the MLKL-RIP1-RIP3 necrosome complex from interacting with its downstream effectors. MLKL is a critical substrate of RIP3 during necrosis induction.
Tags: MLKL | 其他抑制剂/激动剂 | Other Inhibitors/Agonists | 肿瘤生长增殖和凋亡 | Tumor Growth, Proliferation and Apoptosis | MLKL 相关产品
会员中心
我的购物车
我的收藏
咨询热线400-920-2911
Ambeed 公众号
尊敬的 Ambeed 客户您好, 请您选择所在区域,我们将转接对应客服为您服务!